EON Network: March 2026 Newsletter |
The EON Network monthly newsletter includes upcoming webinars, updates on exercise oncology and oncology nutrition related events, publications that may be of interest, and resources. This information is also available on the EON Network webpage. Past newsletters are archived.
|
|
|
Thanks to Dr. Prado for the fantastic presentation!
|
|
|
|
February 2025: Improving Oncology Outcomes Through Targeted Nutritional Assessment and Intervention | Carla Prado, PhD, RD, FCAHS
If you missed the webinar, a recording is available on the EON Network website!
The recording of this webinar session will only be available until May 17, 2026 to comply with the speaker's institutional policies.
|
|
|
Save the Date for the Next Webinar!
|
|
|
April 9, 2026 | 2:00 - 3:00 PM ET
|
|
|
| Coffee consumption and improved colorectal cancer survivorship: from observational to interventional studies
Observational findings from several independent cohorts have consistently shown a beneficial association of coffee consumption after diagnosis with better survival outcomes among patients with colorectal cancer. In support of these data, coffee has been linked to lower risk of metabolic disorders, lower inflammation, and favorable blood biochemical profiles. While the components in coffee that drive these benefits remain unknown, studies of metabolomics and microbiome have identified potential molecules and mechanisms of action underlying coffee's beneficial effects. These data altogether have motivated the conduct of the first randomized control trial of coffee consumption among colorectal cancer survivors (the COMMENCER trial). In this presentation, Dr. Song will review the existing data, present the COMMENCER trial, and discuss the future directions.
The George Washington University School of Medicine and Health Sciences designates this live activity for a maximum of 1.00 AMA PRA Category 1 Credit(s)™ for physicians, physician assistants, and nurse practitioners.
|
|
|
Spotlight: "Effect of a lifestyle intervention during chemotherapy for breast cancer on quality of life"
|
|
|
|
Puklin LS, Li FY, Ferrucci LM, Cartmel B, Harrigan M, McGowan C, Zupa M, Ligibel JA, Sanft T, Irwin ML. Effect of a lifestyle intervention during chemotherapy for breast cancer on quality of life. JNCI Cancer Spectr 2026 Jan 9;10(1):pkaf125. PMID: 41452765
|
"Exercise during active cancer treatment has been shown to preserve physical function and reduce fatigue, anxiety, and depression but less is known about how dietary interventions, particularly when combined with exercise, affect quality of life (QoL) during and after treatment.
In the Lifestyle, Exercise, and Nutrition Early After Diagnosis (LEANer) study, a combined nutrition and exercise intervention for women newly diagnosed with breast cancer and undergoing chemotherapy did not significantly attenuate declines in QoL compared to usual care. These findings raise important questions about how (e.g., PROMIS, FACT, SF-36) and when (e.g., after each chemo cycle vs. just beginning and end of trial) QoL is measured in trials conducted during active treatment, as well as the intensity or “dose” of behavioral lifestyle change needed to meaningfully influence QoL during chemotherapy.
These results underscore the need for more research on combined nutrition and physical activity interventions during cancer treatment and fortunately, findings from the ENICTO Consortium may soon help to fill this gap!"
|
|
|
More Publications of Interest
|
Wilson RL, Giobbie-Hurder A, Bender CM, Brewster AM, Crane TE, Hopkins JO, Masters GA, Pierce LJ, Ligibel JA, Dieli-Conwright CM. Barriers to the adoption of healthy lifestyle behaviors in patients with cancer: results of a national survey. JCO Oncol Pract 2026 Feb 17:OP2501029. PMID: 41701954
Oppong I, Naemi R, Gossett RT. The effects of aerobic and resistance training across eight cancer types: a systematic review. Support Care Cancer 2026 Jan 31;34(2):149. PMID: 41619029
Wilson OWA, Wojcik KM, Kerr EM, Rivera I, Tian E, Schneider JD, Brick R, Berrigan D, Tamura K, Rogers LQ, Demark-Wahnefried W, Street RL Jr, Jayasekera J. Breast cancer survivors' perspectives on a clinical decision tool to support individualized exercise prescriptions and discussions. Support Care Cancer 2026 Jan 29;34(2):139. PMID: 41606253
Henriksson A, Söderlund A, Elfström ML, von Heideken Wågert P. What is helpful and not? Patients' opinions and beliefs of how to support reduced sedentary behavior during cancer treatment-a thematic analysis. Support Care Cancer 2026 Jan 28;34(2):137. PMID: 41593417
André N, Rébillard A, Lertora A, Saada-Weisz M, Gastinger S. What works to engage cancer patients with fatigue in exercise: a scoping review of RCT-based interventions. Support Care Cancer 2026 Jan 20;34(2):110. PMID: 41557173
Bergerot PG, Bergerot CD, Schmitz KH, Pal SK. Remote exercise program for patients with metastatic renal cell carcinoma undergoing immunotherapy: an EXIO Case Series Report. Oncology (Williston Park) 2026;40(1):44-47. PMID: 41701866
|
|
|
|
Exercise in Oncology: Translational Evidence for Exercise Across the Cancer Continuum — Special Collection in Cancer Control Accepting Submissions Now
|
|
|
Submissions for a special collection in Cancer Care entitled "Exercise in Oncology: Translational Evidence for Exercise Across the Cancer Continuum" are being accepted now through October 5, 2026.
For more information about this opportunity or to submit a paper, please visit here.
Justin C. Brown, PhD, a Senior Investigator at AdventHealth and Director of the Exercise and Cancer Biology Research Program, is serving as the Lead Guest Editor for this special collection.
|
Invitation to Submit Additional Opportunities
|
Opportunities such as training workshops, publication submissions, and funding applications are great to share with the EON Network. We invite all to submit relevant opportunities by emailing eonnetwork@bsc.gwu.edu!
|
|
|
Manage your preferences | Opt Out using TrueRemove™
Got this as a forward? Sign up to receive our future emails.
View this email online.
|
6710A Rockledge Drive, Suite 250 | Bethesda, MD 20817 US
|
|
|
This email was sent to .
To continue receiving our emails, add us to your address book.
| |
|
|
